Form 4: Fulgent Genetics Director Linda Marsh Reports Stock Award and Disposal

Director Linda Marsh reported the acquisition of restricted stock units and the disposal of common stock in Fulgent Genetics, Inc.

Summary

• On May 15, 2025, Linda Marsh, a director of Fulgent Genetics, Inc., reported a transaction involving the company's stock.
• Marsh acquired 8,982 shares of common stock through restricted stock units (RSUs).
• The RSUs vest over four years, with 1/4th vesting after 12 months and 1/16th vesting quarterly thereafter, contingent upon continued service.
• On the same day, Marsh disposed of 8,982 shares of common stock.
• Following the reported transactions, Marsh beneficially owns 27,641 shares of Fulgent Genetics, Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting stock transactions. There's no inherent positive or negative implication.

Future Outlook

The vesting schedule of the restricted stock units extends over a four-year period, indicating a long-term incentive for the director.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in company stock, which can be an indicator of their confidence in the company's future performance.

Stakeholder Impact

• The stock transactions of company insiders are of interest to shareholders as they can provide insights into management's perspective on the company's value and future prospects.

Key Dates

Keywords

Form 4, Fulgent Genetics, Director, Stock Transaction, Beneficial Ownership, Restricted Stock Units, FLGT, Marsh